Business-Investing Currently, research into the use of mRNA vaccines for animal agriculture has been gaining traction, with shrimp becoming the latest addition to a growing list of food sources targeted by mRNA gene therapy technology. An Israeli company, ViAqua, has raised $8.25 million from venture capitalists to promote and improve animal health in marine species through its orally administered RNA-particle platform. ViAqua’s vaccine product uses ribonucleic acid interference (RNAi) technology to manipulate gene expression in shrimp. This involves using RNA … Continue reading Skipped The Jab? Big Tech Gears Up For mRNA Laced Meats